The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

Coherus BioSciences, Inc.’s CHRS share price has surged by 6.25%, which has investors questioning if this is right time to sell.

Unresolved Treatment Needs in IPF. Idiopathic Pulmonary Fibrosis (IPF) is a progressive, irreversible, and fatal interstitial lung disease characterized ...

Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...

Goodnight’s ongoing decision to keep SAS private has shaped the company that — more than any other — has shaped the town of ...

The global brain tumor treatment market is undergoing a significant transformation, fueled by remarkable advancements in targeted therapy, immunotherapy, and personalized medicine. With projections ...

The leading Bronchiectasis Companies such as AstraZeneca, Insmed Incorporated, SolAeroMed, Boehringer Ingelheim, CSL Behring, ...

The leading Non-Cystic Fibrosis Bronchiectasis Companies such as Zambon SpA, AstraZeneca, Insmed Incorporated, NovaBiotics, ...

Columnist Jennifer Lynne highlights the emotional and financial strain that many parents face when raising a child with hemophilia.

The analysis by Ontada tracked testing rates withing the US Oncology Network for PD-L1, FGFR2/3, and HER2 biomarkers over 10 years.